A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
NCT07021963 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2025-09-10
Summary
This study mainly evaluates the long-term safety of HRS-1893 in subjects with hypertrophic cardiomyopathy.
Conditions
Interventions
- DRUG
-
HRS-1893 Tablet
HRS-1893 tablet.
Sponsors & Collaborators
-
Shandong Suncadia Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-04
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity
NCT06820099 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial of HRS-1893 in Healthy Volunteers
NCT07033455 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
NCT04164732 ·Status: COMPLETED ·Phase: PHASE2
-
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
NCT06391710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
NCT00354328 ·Status: COMPLETED
-
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT07185776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
NCT06116968 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
NCT02431221 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
NCT04826185 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy
NCT04219826 ·Status: COMPLETED ·Phase: PHASE2
-
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients
NCT03816306 ·Status: COMPLETED
-
A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects
NCT06700083 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01541202 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
NCT01150461 ·Status: COMPLETED ·Phase: PHASE2
-
Early rhBNP on Myocardial Work in Patients With STEMI
NCT04157868 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation
NCT06280768 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
NCT05582395 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01131637 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR
NCT07294495 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
NCT06340048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure
NCT00913653 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
NCT07241104 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
NCT00288730 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2